Related pages Drug Information Summaries Approval Process for New Cancer Treatments Access to Investigational Drugs: Q & A

This page contains brief information about anastrozole and a collection of links to more information from the National Cancer Institute (NCI) and the National Library of Medicine (NLM).

US Brand Name(s):		Arimidex
FDA Approved:		Yes

Anastrozole is approved by the Food and Drug Administration (FDA) to be used alone or together with other treatments for breast cancer in postmenopausal women.

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

Clinical Trial Results: Zoledronic Acid Improves Early Breast Cancer Treatment (06/19/2008) - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Anastrozole, Tamoxifen, and Bone Loss on the ATAC (Arimidex, Tamoxifen Alone or in Combination) Trial (03/26/2008) - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Anastrozole After Tamoxifen for Breast Cancer (08/30/2005) - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Anastrozole Before Surgery for Large Breast Tumors (8/30/2005) - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Anastrozole Prevents Relapse in Breast Cancer (12/08/2004) - Important clinical trial results for this drug, background information, and how the trial was done.

MedlinePlus Information on Anastrozole - A lay language summary of important information about this drug that may include the following:

• warnings about this drug,
• what this drug is used for and how it is used,
• what you should tell your doctor before using this drug,
• what you should know about this drug before using it,
• other drugs that may interact with this drug, and
• possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This NLM patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

Clinical Trials for Anastrozole - Check for trials from NCI's PDQ Cancer Clinical Trials Registry now accepting patients.

Back to Top